CD8A and neoplasm: Sunitinib treatment has the capacity to enhance the CD4+ T and CD8+ T cell intratumoral infiltration in mice [38], and VEGF/VEGFR2 blockade has been shown to improve the infiltration of adoptively transferred T cells into the tumor [62].